Hans-Dirk Düngen, PhD, MD, MBA, SCIRENT CEO and Scientific Director

Hans-Dirk Duengen PhD, MD, MBA

CEO and Scientific Director
Hans-Dirk Duengen is the founder and CEO of . He has collected a wealth of national and international experience in initiating and executing clinical trials as a senior cardiologist at the Charité University Hospital Berlin. Also, he is the author of numerous scientific publications.
Elvis Tahirovic, MBA, MPH, SCIRENT Managing Director

Elvis Tahirovic, MBA, MPH 

 CEO and Managing Director
Elvis Tahirovic is a Co-founder and Managing Director at . He has more than 15 years of experience as a global project manager in the healthcare sector. He is responsible for the company’s business strategy and finances.

SCIRENT is a specialty CRO focused on cardiovascular research. We offer an excellent network of high-performing trial sites in Europe, regulatory consulting, as well as strong medical expertise in support of the design and execution of your programs

Meet us at

Patient recruitment experience & access

 Heart Failure
(Including HFrEF, HFpEF and ADHF)

Chronic Myocarditis
Dilative and Hypertrophic Cardiomyopathy

Valvular Disease 

Lipid disorders & Hypertension
Pulmonary Arterial Hypertension
Acute Ischemic Stroke
Atherosclerosis & CAD
> 1 %

Cardiovascular studies in a wide range of Patient profiles

1 +

Across Europe 

1 yrs

Average experience in CV research of our team members

1 %

of the trials we conduct are in early phase development



Jovan Veskovic, SCIRENT Regional Director Eastern Europe

Jovan Veskovic, MPH, Dipl. Ecc 

CFO and Director Eastern Europe
Jovan Veskovic is a Co-Founder and the Regional Director Eastern Europe at . Since the beginning, he brings in his know-how and passion for managing global clinical trials. He is a management executive with degrees in Public Health and Economics.

Maximilian Posch, MD, MPH 

Chief Medical Officer
Maximilian Posch has a strong background in academic and industry-driven research. As a clinician of internal medicine and clinical pharmacology, he has profound expertise in early phase clinical trials and cardiovascular research. In his career, he conducted more than 200 trials and co-authored numerous peer-reviewed publications.

Book a meeting with our team

* required

If you have any problems with the form above, please get in touch with us directly: contact@scirent.com

Thank you. Your data was submitted successfully.

We will get in touch shortly.

Thank you for your application.

We will get in touch shortly.